Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. G
G logo

G Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Genpact Ltd (G) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
37.160
1 Day change
-0.77%
52 Week Range
50.710
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Based on the data provided, Genpact Ltd (G) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators are bearish, hedge funds are selling, and there are no significant positive trading signals or catalysts to suggest immediate upside potential. While the company has shown modest financial growth and maintains a strong ethical reputation, the lack of strong momentum and mixed analyst ratings suggest holding off on a purchase for now.

Technical Analysis

The technical indicators for Genpact Ltd are bearish. The MACD is negative and expanding downward, RSI is neutral but leaning toward oversold territory, and moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below its pivot level of 38.135, with key support at 37.153 and resistance at 39.116.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low put-call ratios indicate a slightly bullish sentiment in the options market, but the overall volume and open interest trends are not strong enough to confirm a significant trading opportunity.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
10
Buy
0

Positive Catalysts

  • Genpact has been recognized as one of the World's Most Ethical Companies, highlighting its excellence in corporate governance and ESG initiatives. The Advanced Technology Solutions segment continues to show momentum, driving growth in the latest quarter.

Neutral/Negative Catalysts

  • Hedge funds are selling the stock, with a significant increase in selling activity (805.73% over the last quarter). Technical indicators are bearish, and the stock is expected to decline further in the short term. Analysts have lowered price targets, with mixed ratings ranging from Neutral to Buy.

Financial Performance

In Q4 2025, Genpact reported revenue growth of 5.65% YoY, net income growth of 0.83% YoY, EPS growth of 3.80% YoY, and gross margin improvement of 2.33% YoY. While these are positive, the growth rates are modest and do not indicate a strong upward trajectory.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have mixed views on Genpact. Needham maintains a Buy rating but lowered the price target to $50 from $53. Susquehanna has a Neutral rating and lowered the price target to $42 from $50, citing solid execution but concerns about slower growth in the core business.

Wall Street analysts forecast G stock price to rise
8 Analyst Rating
Wall Street analysts forecast G stock price to rise
3 Buy
5 Hold
0 Sell
Moderate Buy
Current: 37.450
sliders
Low
43
Averages
50.57
High
55
Current: 37.450
sliders
Low
43
Averages
50.57
High
55
Needham
Mayank Tandon
Buy
downgrade
$53 -> $50
AI Analysis
2026-02-06
Reason
Needham
Mayank Tandon
Price Target
$53 -> $50
AI Analysis
2026-02-06
downgrade
Buy
Reason
Needham analyst Mayank Tandon lowered the firm's price target on Genpact to $50 from $53 and keeps a Buy rating on the shares. The company posted solid Q4 results, beating estimates on the top and bottom line, driven primarily by its Advanced Technology Solutions segment, the analyst tells investors in a research note.
Susquehanna
Neutral
downgrade
$50 -> $42
2026-02-06
Reason
Susquehanna
Price Target
$50 -> $42
2026-02-06
downgrade
Neutral
Reason
Susquehanna lowered the firm's price target on Genpact to $42 from $50 and keeps a Neutral rating on the shares. The firm said solid Execution, ATS Momentum Continues, Core Questions Remain. Genpact delivered a solid 4Q25, with results modestly ahead of expectations and continued momentum in Advanced Technology Solutions (ATS) offsetting slower growth in the core business.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for G
Unlock Now

People Also Watch